Compounds of the formula I: ##STR00001## or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein m, k, B, R.sup.1, R.sup.2 and R.sup.3 are those defined herein, and compositions comprising the same. Also provided are methods for preparing compounds of formula I and using the same in treating p38 mediated disorders in a patient.